Rosalind Advisors’s Grace Therapeutics GRCE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.02M Buy
+476,190
New +$1.06M 0.33% 33

Other funds holding GRCE

Rosalind Advisors's GRCE Position: Q3 2026 in Review

Rosalind Advisors opened a new position in Grace Therapeutics (GRCE) in Q3 2026: 476,190 shares worth $1.02M. The stake represents 0.33% of the portfolio and ranks #33 among its holdings.

38 funds tracked by Wall St. Rank hold GRCE as of Q3 2026.

  • Rosalind Advisors held 476,190 shares of Grace Therapeutics worth $1.02M as of Q3 2026.
  • Grace Therapeutics was a new Rosalind Advisors position in Q3 2026.
  • Grace Therapeutics made up 0.33% of Rosalind Advisors's portfolio in Q3 2026, its #33 holding.
  • 38 funds tracked by Wall St. Rank held Grace Therapeutics as of Q3 2026.

Based on Rosalind Advisors's 13F filing for Q3 2026, filed 16 Nov 2026.